Methylprednisolone Sodium Succinate NDC 63323-265

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-265Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0265Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-265-30	63323026530	1 VIAL, MULTI-DOSE in 1 CARTON (63323-265-30) / 16 mL in 1 VIAL, MULTI-DOSEMarketed from Nov 30, 2004

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methylprednisolone Sodium Succinate
Generic name (nonproprietary): methylprednisolone sodium succinate
Active ingredients: Methylprednisolone sodium succinate — 1 g/16mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intramuscular, Intravenous
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040612
Marketing start: Nov 30, 2004
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 63323-265_dc369096-3042-4942-9aeb-bbdf98f35bb8SPL ID dc369096-3042-4942-9aeb-bbdf98f35bb8SPL set ID c5d22210-73c6-4697-a267-75e243508642RxCUI 311659, 314099, 1743704UNII LEC9GKY20KUPC 0363323255015, 0363323265304, 0363323258016
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323026530 followed by a unit qualifier and the quantity

Package 63323-0265-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 2, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of Methylprednisolone Sodium Succinate for Injection sterile powder is indicated as follows: Allergic states : Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases : Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe e…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)